The newspaper reported the comment Sept 22. It follows the federal agency launching an inquiry in June into the business practices of the nation’s six largest PBMs: CVS Caremark, Express Scripts, OptumRx, Humana, Prime Therapeutics and MedImpact Healthcare Systems.
“Today, it is axiomatic that antitrust does not protect small business. And that the lodestar of antitrust is not fairness, but efficiency,” Mr. Bedoya said a conference in Minneapolis. “How did this happen? … I think it is time to return to fairness.”
Mr. Bedoya was appointed to the FTC by President Joe Biden and was confirmed by the Senate in May. His term ends in 2026.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.